These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25725243)

  • 1. The Kidney Early Evaluation Program (KEEP) of Japan.
    Nitta K; Okada K; Yanai M; Takahashi S
    Clin Nephrol; 2015; 83(7 Suppl 1):52-5. PubMed ID: 25725243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period.
    Takahashi S; Okada K; Yanai M
    Kidney Int Suppl; 2010 Mar; (116):S17-23. PubMed ID: 20186175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of participants in the KEEP Mexico's chronic kidney disease screening program.
    Obrador GT; Villa AR; Olvera N; Gutiérrez V; Contreras D; Reyes R
    Arch Med Res; 2013 Nov; 44(8):650-4. PubMed ID: 24211753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Whaley-Connell AT; Sowers JR; Stevens LA; McFarlane SI; Shlipak MG; Norris KC; Chen SC; Qiu Y; Wang C; Li S; Vassalotti JA; Collins AJ;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S13-20. PubMed ID: 18359403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    McCullough PA; Li S; Jurkovitz CT; Stevens LA; Wang C; Collins AJ; Chen SC; Norris KC; McFarlane SI; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti JA; Whaley-Connell AT;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S38-45. PubMed ID: 18359407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US.
    Obrador GT; García-García G; Villa AR; Rubilar X; Olvera N; Ferreira E; Virgen M; Gutiérrez-Padilla JA; Plascencia-Alonso M; Mendoza-García M; Plascencia-Pérez S
    Kidney Int Suppl; 2010 Mar; (116):S2-8. PubMed ID: 20186176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004.
    Whaley-Connell AT; Sowers JR; McFarlane SI; Norris KC; Chen SC; Li S; Qiu Y; Wang C; Stevens LA; Vassalotti JA; Collins AJ;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S21-9. PubMed ID: 18359404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    McFarlane SI; Chen SC; Whaley-Connell AT; Sowers JR; Vassalotti JA; Salifu MO; Li S; Wang C; Bakris G; McCullough PA; Collins AJ; Norris KC;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S46-55. PubMed ID: 18359408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population.
    Jurkovitz CT; Qiu Y; Wang C; Gilbertson DT; Brown WW
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S3-12. PubMed ID: 18359405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
    Kalaitzidis R; Li S; Wang C; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S22-31. PubMed ID: 19285608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.
    Rao MV; Qiu Y; Wang C; Bakris G
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S30-7. PubMed ID: 18359406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem.
    Vassalotti JA; Li S; Chen SC; Collins AJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S107-14. PubMed ID: 19231754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participant follow-up in the Kidney Early Evaluation Program (KEEP) after initial detection.
    Collins AJ; Li S; Chen SC; Vassalotti JA
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S69-76. PubMed ID: 18359410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and related risk factors of chronic kidney disease among adults in Luxembourg: evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) study.
    Alkerwi A; Sauvageot N; El Bahi I; Delagardelle C; Beissel J; Noppe S; Roderick PJ; Mindell JS; Stranges S
    BMC Nephrol; 2017 Dec; 18(1):358. PubMed ID: 29221436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of screening for CKD among the elderly or persons with low socioeconomic status.
    Vart P; Reijneveld SA; Bültmann U; Gansevoort RT
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):562-70. PubMed ID: 25779994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hyperuricaemia on the chronic kidney disease-associated risk factors in a community-based population.
    Tsumuraya Y; Hirayama T; Tozuka E; Furuta W; Utsugi S; Tsuchiya A; Hishida A; Kumagai H
    Nephrology (Carlton); 2015 Jun; 20(6):399-404. PubMed ID: 25651516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for proteinuria: the National Kidney Foundation of Malaysia Lifecheck Health Screening programme.
    Ong LM; Punithavathi N; Thurairatnam D; Zainal H; Beh ML; Morad Z; Lee SY; Bavanandan S; Kok LS
    Nephrology (Carlton); 2013 Aug; 18(8):569-75. PubMed ID: 23782264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.